
It is widely known that Takeda is keen to build its portfolio in oncology and it has made another move …

Merck has announced its approval of NICE’s decision to expand its recommendation of Erbitux (cetuximab) to include its use as …

As part of Shire’s mega-merger with Baxalta, it suddenly had a massive manufacturing network that spanned 17 sites across seven …

Zynerba Pharmaceuticals had hoped that its anti-seizure therapy could replicate the kind of success leading competitors had achieved in showing …

Moderna Therapeutics, a clinical stage biotechnology company, has appointed Juan Andres to the position of Senior Vice President of Late …

Bayer has announced that it has received European Commission approval for its treatment of hepatocellular carcinoma, a type of liver …

NHS England has announced that it will finally make the HIV-preventing drug, PrEP, available to those at risk with the …

Vernalis has been given a second CRL for a cough and cold treatment by the FDA this year. The therapy, …

French firm Valneva has announced that its Lyme disease vaccine, known at this stage only by VLA15, has been fast-tracked …

Jeff Huber, a former Google executive who spent 14 years at the company, has announced that he will step from …

Another week passes by, and the headlines have seen some shocking stories, such as the news that the UK is …

Bristol-Myers Squibb has agreed a deal to acquire IFM Therapeutics for a potential $2.3 billion. The latter is a biotech …

Facebook CEO Mark Zuckerberg and philanthropist Priscilla Chan have continued their quest to improve worldwide healthcare with the latest donation …

There are currently no treatments that are able to slow the development of Parkinson’s disease. This unmet medical need will …

Teva has released its second quarter financials and they do not make for great reading if you’re an investor. The …